Prophylactic HIV Drug Market, Global Outlook and Forecast 2022-2028

March 2022 | 75 pages | ID: PEB9114572D4EN
Market Monitor Global

Abstracts

HIV is one of the leading cause of death worldwide affecting millions of people. HIV has become the chief contributor to the global burden diseases.

This report contains market size and forecasts of Prophylactic HIV Drug in global, including the following market information:

Global Prophylactic HIV Drug Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global Prophylactic HIV Drug Market Sales, 2017-2022, 2023-2028, (K Units)

Global top five Prophylactic HIV Drug companies in 2021 (%)

The global Prophylactic HIV Drug market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Nucleoside or Nucleotide Reverse Transcriptase Inhibitors (NRTI) Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Prophylactic HIV Drug include Gilead Sciences, Merck, Mylan, Cipla, Bristol-Myers Squibb and Roche, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Prophylactic HIV Drug manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Prophylactic HIV Drug Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Prophylactic HIV Drug Market Segment Percentages, by Type, 2021 (%)

• Nucleoside or Nucleotide Reverse Transcriptase Inhibitors (NRTI)
• Integrase Inhibitor

Global Prophylactic HIV Drug Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Prophylactic HIV Drug Market Segment Percentages, by Application, 2021 (%)

• Hospital Pharmacy
• Retail Pharmacy
• Online Pharmacy

Global Prophylactic HIV Drug Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Prophylactic HIV Drug Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Prophylactic HIV Drug revenues in global market, 2017-2022 (Estimated), ($ millions)

Key companies Prophylactic HIV Drug revenues share in global market, 2021 (%)

Key companies Prophylactic HIV Drug sales in global market, 2017-2022 (Estimated), (K Units)

Key companies Prophylactic HIV Drug sales share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Gilead Sciences
• Merck
• Mylan
• Cipla
• Bristol-Myers Squibb
• Roche

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Prophylactic HIV Drug Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Prophylactic HIV Drug Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL PROPHYLACTIC HIV DRUG OVERALL MARKET SIZE

2.1 Global Prophylactic HIV Drug Market Size: 2021 VS 2028
2.2 Global Prophylactic HIV Drug Revenue, Prospects & Forecasts: 2017-2028
2.3 Global Prophylactic HIV Drug Sales: 2017-2028

3 COMPANY LANDSCAPE

3.1 Top Prophylactic HIV Drug Players in Global Market
3.2 Top Global Prophylactic HIV Drug Companies Ranked by Revenue
3.3 Global Prophylactic HIV Drug Revenue by Companies
3.4 Global Prophylactic HIV Drug Sales by Companies
3.5 Global Prophylactic HIV Drug Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 Prophylactic HIV Drug Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers Prophylactic HIV Drug Product Type
3.8 Tier 1, Tier 2 and Tier 3 Prophylactic HIV Drug Players in Global Market
  3.8.1 List of Global Tier 1 Prophylactic HIV Drug Companies
  3.8.2 List of Global Tier 2 and Tier 3 Prophylactic HIV Drug Companies

4 SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 By Type - Global Prophylactic HIV Drug Market Size Markets, 2021 & 2028
  4.1.2 Nucleoside or Nucleotide Reverse Transcriptase Inhibitors (NRTI)
  4.1.3 Integrase Inhibitor
4.2 By Type - Global Prophylactic HIV Drug Revenue & Forecasts
  4.2.1 By Type - Global Prophylactic HIV Drug Revenue, 2017-2022
  4.2.2 By Type - Global Prophylactic HIV Drug Revenue, 2023-2028
  4.2.3 By Type - Global Prophylactic HIV Drug Revenue Market Share, 2017-2028
4.3 By Type - Global Prophylactic HIV Drug Sales & Forecasts
  4.3.1 By Type - Global Prophylactic HIV Drug Sales, 2017-2022
  4.3.2 By Type - Global Prophylactic HIV Drug Sales, 2023-2028
  4.3.3 By Type - Global Prophylactic HIV Drug Sales Market Share, 2017-2028
4.4 By Type - Global Prophylactic HIV Drug Price (Manufacturers Selling Prices), 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Prophylactic HIV Drug Market Size, 2021 & 2028
  5.1.2 Hospital Pharmacy
  5.1.3 Retail Pharmacy
  5.1.4 Online Pharmacy
5.2 By Application - Global Prophylactic HIV Drug Revenue & Forecasts
  5.2.1 By Application - Global Prophylactic HIV Drug Revenue, 2017-2022
  5.2.2 By Application - Global Prophylactic HIV Drug Revenue, 2023-2028
  5.2.3 By Application - Global Prophylactic HIV Drug Revenue Market Share, 2017-2028
5.3 By Application - Global Prophylactic HIV Drug Sales & Forecasts
  5.3.1 By Application - Global Prophylactic HIV Drug Sales, 2017-2022
  5.3.2 By Application - Global Prophylactic HIV Drug Sales, 2023-2028
  5.3.3 By Application - Global Prophylactic HIV Drug Sales Market Share, 2017-2028
5.4 By Application - Global Prophylactic HIV Drug Price (Manufacturers Selling Prices), 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Prophylactic HIV Drug Market Size, 2021 & 2028
6.2 By Region - Global Prophylactic HIV Drug Revenue & Forecasts
  6.2.1 By Region - Global Prophylactic HIV Drug Revenue, 2017-2022
  6.2.2 By Region - Global Prophylactic HIV Drug Revenue, 2023-2028
  6.2.3 By Region - Global Prophylactic HIV Drug Revenue Market Share, 2017-2028
6.3 By Region - Global Prophylactic HIV Drug Sales & Forecasts
  6.3.1 By Region - Global Prophylactic HIV Drug Sales, 2017-2022
  6.3.2 By Region - Global Prophylactic HIV Drug Sales, 2023-2028
  6.3.3 By Region - Global Prophylactic HIV Drug Sales Market Share, 2017-2028
6.4 North America
  6.4.1 By Country - North America Prophylactic HIV Drug Revenue, 2017-2028
  6.4.2 By Country - North America Prophylactic HIV Drug Sales, 2017-2028
  6.4.3 US Prophylactic HIV Drug Market Size, 2017-2028
  6.4.4 Canada Prophylactic HIV Drug Market Size, 2017-2028
  6.4.5 Mexico Prophylactic HIV Drug Market Size, 2017-2028
6.5 Europe
  6.5.1 By Country - Europe Prophylactic HIV Drug Revenue, 2017-2028
  6.5.2 By Country - Europe Prophylactic HIV Drug Sales, 2017-2028
  6.5.3 Germany Prophylactic HIV Drug Market Size, 2017-2028
  6.5.4 France Prophylactic HIV Drug Market Size, 2017-2028
  6.5.5 U.K. Prophylactic HIV Drug Market Size, 2017-2028
  6.5.6 Italy Prophylactic HIV Drug Market Size, 2017-2028
  6.5.7 Russia Prophylactic HIV Drug Market Size, 2017-2028
  6.5.8 Nordic Countries Prophylactic HIV Drug Market Size, 2017-2028
  6.5.9 Benelux Prophylactic HIV Drug Market Size, 2017-2028
6.6 Asia
  6.6.1 By Region - Asia Prophylactic HIV Drug Revenue, 2017-2028
  6.6.2 By Region - Asia Prophylactic HIV Drug Sales, 2017-2028
  6.6.3 China Prophylactic HIV Drug Market Size, 2017-2028
  6.6.4 Japan Prophylactic HIV Drug Market Size, 2017-2028
  6.6.5 South Korea Prophylactic HIV Drug Market Size, 2017-2028
  6.6.6 Southeast Asia Prophylactic HIV Drug Market Size, 2017-2028
  6.6.7 India Prophylactic HIV Drug Market Size, 2017-2028
6.7 South America
  6.7.1 By Country - South America Prophylactic HIV Drug Revenue, 2017-2028
  6.7.2 By Country - South America Prophylactic HIV Drug Sales, 2017-2028
  6.7.3 Brazil Prophylactic HIV Drug Market Size, 2017-2028
  6.7.4 Argentina Prophylactic HIV Drug Market Size, 2017-2028
6.8 Middle East & Africa
  6.8.1 By Country - Middle East & Africa Prophylactic HIV Drug Revenue, 2017-2028
  6.8.2 By Country - Middle East & Africa Prophylactic HIV Drug Sales, 2017-2028
  6.8.3 Turkey Prophylactic HIV Drug Market Size, 2017-2028
  6.8.4 Israel Prophylactic HIV Drug Market Size, 2017-2028
  6.8.5 Saudi Arabia Prophylactic HIV Drug Market Size, 2017-2028
  6.8.6 UAE Prophylactic HIV Drug Market Size, 2017-2028

7 MANUFACTURERS & BRANDS PROFILES

7.1 Gilead Sciences
  7.1.1 Gilead Sciences Corporate Summary
  7.1.2 Gilead Sciences Business Overview
  7.1.3 Gilead Sciences Prophylactic HIV Drug Major Product Offerings
  7.1.4 Gilead Sciences Prophylactic HIV Drug Sales and Revenue in Global (2017-2022)
  7.1.5 Gilead Sciences Key News
7.2 Merck
  7.2.1 Merck Corporate Summary
  7.2.2 Merck Business Overview
  7.2.3 Merck Prophylactic HIV Drug Major Product Offerings
  7.2.4 Merck Prophylactic HIV Drug Sales and Revenue in Global (2017-2022)
  7.2.5 Merck Key News
7.3 Mylan
  7.3.1 Mylan Corporate Summary
  7.3.2 Mylan Business Overview
  7.3.3 Mylan Prophylactic HIV Drug Major Product Offerings
  7.3.4 Mylan Prophylactic HIV Drug Sales and Revenue in Global (2017-2022)
  7.3.5 Mylan Key News
7.4 Cipla
  7.4.1 Cipla Corporate Summary
  7.4.2 Cipla Business Overview
  7.4.3 Cipla Prophylactic HIV Drug Major Product Offerings
  7.4.4 Cipla Prophylactic HIV Drug Sales and Revenue in Global (2017-2022)
  7.4.5 Cipla Key News
7.5 Bristol-Myers Squibb
  7.5.1 Bristol-Myers Squibb Corporate Summary
  7.5.2 Bristol-Myers Squibb Business Overview
  7.5.3 Bristol-Myers Squibb Prophylactic HIV Drug Major Product Offerings
  7.5.4 Bristol-Myers Squibb Prophylactic HIV Drug Sales and Revenue in Global (2017-2022)
  7.5.5 Bristol-Myers Squibb Key News
7.6 Roche
  7.6.1 Roche Corporate Summary
  7.6.2 Roche Business Overview
  7.6.3 Roche Prophylactic HIV Drug Major Product Offerings
  7.6.4 Roche Prophylactic HIV Drug Sales and Revenue in Global (2017-2022)
  7.6.5 Roche Key News

8 GLOBAL PROPHYLACTIC HIV DRUG PRODUCTION CAPACITY, ANALYSIS

8.1 Global Prophylactic HIV Drug Production Capacity, 2017-2028
8.2 Prophylactic HIV Drug Production Capacity of Key Manufacturers in Global Market
8.3 Global Prophylactic HIV Drug Production by Region

9 KEY MARKET TRENDS, OPPORTUNITY, DRIVERS AND RESTRAINTS

9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints

10 PROPHYLACTIC HIV DRUG SUPPLY CHAIN ANALYSIS

10.1 Prophylactic HIV Drug Industry Value Chain
10.2 Prophylactic HIV Drug Upstream Market
10.3 Prophylactic HIV Drug Downstream and Clients
10.4 Marketing Channels Analysis
  10.4.1 Marketing Channels
  10.4.2 Prophylactic HIV Drug Distributors and Sales Agents in Global

11 CONCLUSION

12 APPENDIX

12.1 Note
12.2 Examples of Clients
12.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Key Players of Prophylactic HIV Drug in Global Market
Table 2. Top Prophylactic HIV Drug Players in Global Market, Ranking by Revenue (2021)
Table 3. Global Prophylactic HIV Drug Revenue by Companies, (US$, Mn), 2017-2022
Table 4. Global Prophylactic HIV Drug Revenue Share by Companies, 2017-2022
Table 5. Global Prophylactic HIV Drug Sales by Companies, (K Units), 2017-2022
Table 6. Global Prophylactic HIV Drug Sales Share by Companies, 2017-2022
Table 7. Key Manufacturers Prophylactic HIV Drug Price (2017-2022) & (USD/Unit)
Table 8. Global Manufacturers Prophylactic HIV Drug Product Type
Table 9. List of Global Tier 1 Prophylactic HIV Drug Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Prophylactic HIV Drug Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Prophylactic HIV Drug Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Global Prophylactic HIV Drug Revenue (US$, Mn), 2017-2022
Table 13. By Type - Global Prophylactic HIV Drug Revenue (US$, Mn), 2023-2028
Table 14. By Type - Global Prophylactic HIV Drug Sales (K Units), 2017-2022
Table 15. By Type - Global Prophylactic HIV Drug Sales (K Units), 2023-2028
Table 16. By Application – Global Prophylactic HIV Drug Revenue, (US$, Mn), 2021 & 2028
Table 17. By Application - Global Prophylactic HIV Drug Revenue (US$, Mn), 2017-2022
Table 18. By Application - Global Prophylactic HIV Drug Revenue (US$, Mn), 2023-2028
Table 19. By Application - Global Prophylactic HIV Drug Sales (K Units), 2017-2022
Table 20. By Application - Global Prophylactic HIV Drug Sales (K Units), 2023-2028
Table 21. By Region – Global Prophylactic HIV Drug Revenue, (US$, Mn), 2021 VS 2028
Table 22. By Region - Global Prophylactic HIV Drug Revenue (US$, Mn), 2017-2022
Table 23. By Region - Global Prophylactic HIV Drug Revenue (US$, Mn), 2023-2028
Table 24. By Region - Global Prophylactic HIV Drug Sales (K Units), 2017-2022
Table 25. By Region - Global Prophylactic HIV Drug Sales (K Units), 2023-2028
Table 26. By Country - North America Prophylactic HIV Drug Revenue, (US$, Mn), 2017-2022
Table 27. By Country - North America Prophylactic HIV Drug Revenue, (US$, Mn), 2023-2028
Table 28. By Country - North America Prophylactic HIV Drug Sales, (K Units), 2017-2022
Table 29. By Country - North America Prophylactic HIV Drug Sales, (K Units), 2023-2028
Table 30. By Country - Europe Prophylactic HIV Drug Revenue, (US$, Mn), 2017-2022
Table 31. By Country - Europe Prophylactic HIV Drug Revenue, (US$, Mn), 2023-2028
Table 32. By Country - Europe Prophylactic HIV Drug Sales, (K Units), 2017-2022
Table 33. By Country - Europe Prophylactic HIV Drug Sales, (K Units), 2023-2028
Table 34. By Region - Asia Prophylactic HIV Drug Revenue, (US$, Mn), 2017-2022
Table 35. By Region - Asia Prophylactic HIV Drug Revenue, (US$, Mn), 2023-2028
Table 36. By Region - Asia Prophylactic HIV Drug Sales, (K Units), 2017-2022
Table 37. By Region - Asia Prophylactic HIV Drug Sales, (K Units), 2023-2028
Table 38. By Country - South America Prophylactic HIV Drug Revenue, (US$, Mn), 2017-2022
Table 39. By Country - South America Prophylactic HIV Drug Revenue, (US$, Mn), 2023-2028
Table 40. By Country - South America Prophylactic HIV Drug Sales, (K Units), 2017-2022
Table 41. By Country - South America Prophylactic HIV Drug Sales, (K Units), 2023-2028
Table 42. By Country - Middle East & Africa Prophylactic HIV Drug Revenue, (US$, Mn), 2017-2022
Table 43. By Country - Middle East & Africa Prophylactic HIV Drug Revenue, (US$, Mn), 2023-2028
Table 44. By Country - Middle East & Africa Prophylactic HIV Drug Sales, (K Units), 2017-2022
Table 45. By Country - Middle East & Africa Prophylactic HIV Drug Sales, (K Units), 2023-2028
Table 46. Gilead Sciences Corporate Summary
Table 47. Gilead Sciences Prophylactic HIV Drug Product Offerings
Table 48. Gilead Sciences Prophylactic HIV Drug Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 49. Merck Corporate Summary
Table 50. Merck Prophylactic HIV Drug Product Offerings
Table 51. Merck Prophylactic HIV Drug Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 52. Mylan Corporate Summary
Table 53. Mylan Prophylactic HIV Drug Product Offerings
Table 54. Mylan Prophylactic HIV Drug Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 55. Cipla Corporate Summary
Table 56. Cipla Prophylactic HIV Drug Product Offerings
Table 57. Cipla Prophylactic HIV Drug Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 58. Bristol-Myers Squibb Corporate Summary
Table 59. Bristol-Myers Squibb Prophylactic HIV Drug Product Offerings
Table 60. Bristol-Myers Squibb Prophylactic HIV Drug Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 61. Roche Corporate Summary
Table 62. Roche Prophylactic HIV Drug Product Offerings
Table 63. Roche Prophylactic HIV Drug Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 64. Prophylactic HIV Drug Production Capacity (K Units) of Key Manufacturers in Global Market, 2020-2022 (K Units)
Table 65. Global Prophylactic HIV Drug Capacity Market Share of Key Manufacturers, 2020-2022
Table 66. Global Prophylactic HIV Drug Production by Region, 2017-2022 (K Units)
Table 67. Global Prophylactic HIV Drug Production by Region, 2023-2028 (K Units)
Table 68. Prophylactic HIV Drug Market Opportunities & Trends in Global Market
Table 69. Prophylactic HIV Drug Market Drivers in Global Market
Table 70. Prophylactic HIV Drug Market Restraints in Global Market
Table 71. Prophylactic HIV Drug Raw Materials
Table 72. Prophylactic HIV Drug Raw Materials Suppliers in Global Market
Table 73. Typical Prophylactic HIV Drug Downstream
Table 74. Prophylactic HIV Drug Downstream Clients in Global Market
Table 75. Prophylactic HIV Drug Distributors and Sales Agents in Global Market

List Of Figures

LIST OF FIGURES

Figure 1. Prophylactic HIV Drug Segment by Type
Figure 2. Prophylactic HIV Drug Segment by Application
Figure 3. Global Prophylactic HIV Drug Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Prophylactic HIV Drug Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Prophylactic HIV Drug Revenue, 2017-2028 (US$, Mn)
Figure 7. Prophylactic HIV Drug Sales in Global Market: 2017-2028 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Prophylactic HIV Drug Revenue in 2021
Figure 9. By Type - Global Prophylactic HIV Drug Sales Market Share, 2017-2028
Figure 10. By Type - Global Prophylactic HIV Drug Revenue Market Share, 2017-2028
Figure 11. By Type - Global Prophylactic HIV Drug Price (USD/Unit), 2017-2028
Figure 12. By Application - Global Prophylactic HIV Drug Sales Market Share, 2017-2028
Figure 13. By Application - Global Prophylactic HIV Drug Revenue Market Share, 2017-2028
Figure 14. By Application - Global Prophylactic HIV Drug Price (USD/Unit), 2017-2028
Figure 15. By Region - Global Prophylactic HIV Drug Sales Market Share, 2017-2028
Figure 16. By Region - Global Prophylactic HIV Drug Revenue Market Share, 2017-2028
Figure 17. By Country - North America Prophylactic HIV Drug Revenue Market Share, 2017-2028
Figure 18. By Country - North America Prophylactic HIV Drug Sales Market Share, 2017-2028
Figure 19. US Prophylactic HIV Drug Revenue, (US$, Mn), 2017-2028
Figure 20. Canada Prophylactic HIV Drug Revenue, (US$, Mn), 2017-2028
Figure 21. Mexico Prophylactic HIV Drug Revenue, (US$, Mn), 2017-2028
Figure 22. By Country - Europe Prophylactic HIV Drug Revenue Market Share, 2017-2028
Figure 23. By Country - Europe Prophylactic HIV Drug Sales Market Share, 2017-2028
Figure 24. Germany Prophylactic HIV Drug Revenue, (US$, Mn), 2017-2028
Figure 25. France Prophylactic HIV Drug Revenue, (US$, Mn), 2017-2028
Figure 26. U.K. Prophylactic HIV Drug Revenue, (US$, Mn), 2017-2028
Figure 27. Italy Prophylactic HIV Drug Revenue, (US$, Mn), 2017-2028
Figure 28. Russia Prophylactic HIV Drug Revenue, (US$, Mn), 2017-2028
Figure 29. Nordic Countries Prophylactic HIV Drug Revenue, (US$, Mn), 2017-2028
Figure 30. Benelux Prophylactic HIV Drug Revenue, (US$, Mn), 2017-2028
Figure 31. By Region - Asia Prophylactic HIV Drug Revenue Market Share, 2017-2028
Figure 32. By Region - Asia Prophylactic HIV Drug Sales Market Share, 2017-2028
Figure 33. China Prophylactic HIV Drug Revenue, (US$, Mn), 2017-2028
Figure 34. Japan Prophylactic HIV Drug Revenue, (US$, Mn), 2017-2028
Figure 35. South Korea Prophylactic HIV Drug Revenue, (US$, Mn), 2017-2028
Figure 36. Southeast Asia Prophylactic HIV Drug Revenue, (US$, Mn), 2017-2028
Figure 37. India Prophylactic HIV Drug Revenue, (US$, Mn), 2017-2028
Figure 38. By Country - South America Prophylactic HIV Drug Revenue Market Share, 2017-2028
Figure 39. By Country - South America Prophylactic HIV Drug Sales Market Share, 2017-2028
Figure 40. Brazil Prophylactic HIV Drug Revenue, (US$, Mn), 2017-2028
Figure 41. Argentina Prophylactic HIV Drug Revenue, (US$, Mn), 2017-2028
Figure 42. By Country - Middle East & Africa Prophylactic HIV Drug Revenue Market Share, 2017-2028
Figure 43. By Country - Middle East & Africa Prophylactic HIV Drug Sales Market Share, 2017-2028
Figure 44. Turkey Prophylactic HIV Drug Revenue, (US$, Mn), 2017-2028
Figure 45. Israel Prophylactic HIV Drug Revenue, (US$, Mn), 2017-2028
Figure 46. Saudi Arabia Prophylactic HIV Drug Revenue, (US$, Mn), 2017-2028
Figure 47. UAE Prophylactic HIV Drug Revenue, (US$, Mn), 2017-2028
Figure 48. Global Prophylactic HIV Drug Production Capacity (K Units), 2017-2028
Figure 49. The Percentage of Production Prophylactic HIV Drug by Region, 2021 VS 2028
Figure 50. Prophylactic HIV Drug Industry Value Chain
Figure 51. Marketing Channels